EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Determinants and Temporal Trends of Inappropriate Azithromycin Use in Hospitalized Adults with COVID-19: A Retrospective Pharmacoepidemiologic Cohort Study

Fitim Alidema, Arieta Hasani Alidema, Miranda Sejdiu Abazi, Saranda Sejdiu Sadiku, Arben Abazi

Pharmacoepidemiology · 10.06.2026 · 5 (2) · 19

DOI: 10.3390/pharma5020019 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pharmacoepidemiology, online erschienen am 10.06.2026. Verfasst von Fitim Alidema und 4 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic was associated with extensive empirical antibiotic exposure despite the predominantly viral etiology of the disease. Evaluating patterns of azithromycin use, prescribing determinants, and appropriateness provides insight into real-world antibiotic use under conditions of diagnostic uncertainty.

Methods

We performed a retrospective cohort study including 3200 adult patients hospitalized with laboratory-confirmed COVID-19 at the General Hospital in Ferizaj between June 2020 and June 2022. Demographic characteristics, comorbidities, markers of disease severity, laboratory parameters, and antibiotic exposure were extracted from medical records. Azithromycin prescriptions were classified as appropriate, potentially appropriate, or inappropriate based on predefined clinical and laboratory indicators suggestive of bacterial co-infection. Drug utilization patterns, temporal trends, and independent determinants of inappropriate prescribing were assessed using descriptive analyses and multivariable logistic regression modeling.

Results

Among 3200 hospitalized patients, 1968 (61.5%) received azithromycin. Of these prescriptions, 612 (31.1%) were classified as appropriate, 418 (21.3%) as potentially appropriate, and 938 (47.6%) as inappropriate. The proportion of inappropriate use decreased over time, from 52.4% in 2020–2021 to 38.7% in 2022 (p < 0.001). However, a substantial proportion of prescriptions remained inappropriate throughout the study period. In multivariable analysis, absence of laboratory markers suggestive of bacterial infection (OR 2.41; 95% CI 1.98–2.93), concomitant use of more than one antibiotic (OR 1.67; 95% CI 1.32–2.11), and lower clinical severity at admission (OR 1.54; 95% CI 1.21–1.95) were independently associated with inappropriate azithromycin prescribing.

Conclusions

Azithromycin use was frequent among hospitalized adults with COVID-19, and a considerable proportion of prescriptions lacked clinical or laboratory justification. Although prescribing patterns changed over time, the persistence of inappropriate use highlights ongoing challenges in aligning antibiotic use with emerging evidence. These findings contribute to the understanding of antibiotic utilization patterns in acute care settings and underscore the importance of integrating objective diagnostic indicators into antimicrobial decision-making to strengthen stewardship practice.

Zitieren

APA

Alidema, F., Alidema, A. H., Abazi, M. S., Sadiku, S. S., & Abazi, A. (2026). Determinants and Temporal Trends of Inappropriate Azithromycin Use in Hospitalized Adults with COVID-19: A Retrospective Pharmacoepidemiologic Cohort Study. Pharmacoepidemiology, 5(2), 19. https://doi.org/10.3390/pharma5020019

Vancouver

Alidema F, Alidema AH, Abazi MS, Sadiku SS, Abazi A. Determinants and Temporal Trends of Inappropriate Azithromycin Use in Hospitalized Adults with COVID-19: A Retrospective Pharmacoepidemiologic Cohort Study. Pharmacoepidemiology. 2026;5(2):19. doi:10.3390/pharma5020019

BibTeX
@article{Alidema2026,
  author = {Alidema, Fitim and Alidema, Arieta Hasani and Abazi, Miranda Sejdiu and Sadiku, Saranda Sejdiu and Abazi, Arben},
  title = {Determinants and Temporal Trends of Inappropriate Azithromycin Use in Hospitalized Adults with COVID-19: A Retrospective Pharmacoepidemiologic Cohort Study},
  journal = {Pharmacoepidemiology},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {19},
  doi = {10.3390/pharma5020019}
}
Kostenlos starten →